IFORY
Live / Registered — Registered — Section 8 accepted (as of 26 Feb 2026)
What this means for you
Registered since 08 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88043881
- Registration number
- 5877418
- Mark type
- Word mark
- Filed
- 19 Jul 2018
- Published for opposition
- 23 Jul 2019
- Registered
- 08 Oct 2019
- Attorney of record
- Igxtelle Anyen Mbah Acha Dopgima
Goods and services
- Class 005 — Pharmaceuticals: Antibiotic ointments; Balms for medical purposes; [ Cardiotonics; Frostbite salve for pharmaceutical purposes; ] Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Medical dressings; Medical and surgical dressings [ ; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Nutritive substances for micro-organisms for medical use; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents ]
Owner
- Zhengzhou Daohe Medical Biological Technology Co.,Ltd, Zhengzhou, CN
- Zhengzhou Daohe Medical Biological Technology Co.,Ltd, Zhengzhou, CN
- Zhengzhou Daohe Medical Biological Technology Co.,Ltd, Zhengzhou, CN
Prosecution history
- 26 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 26 Feb 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 23 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Sept 2025 — TEAS SECTION 8 RECEIVED
- 08 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 23 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jul 2019 — PUBLISHED FOR OPPOSITION
- 03 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jun 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jun 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Jun 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jun 2019 — ASSIGNED TO LIE
- 07 Jun 2019 — NOTICE OF REVIVAL - E-MAILED
- 07 Jun 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED